Literature DB >> 35513715

Clinical determinants of cerebrovascular reactivity in very preterm infants during the transitional period.

Topun Austin1, Luigi Corvaglia2,3, Silvia Martini4,5, Marek Czosnyka6, Peter Smielewski6, Marica Iommi7, Silvia Galletti2,3, Francesca Vitali2, Vittoria Paoletti2, Federica Camela2.   

Abstract

BACKGROUND: Preterm infants are at enhanced risk of brain injury due to altered cerebral haemodynamics during postnatal transition. This observational study aimed to assess the clinical determinants of transitional cerebrovascular reactivity and its association with intraventricular haemorrhage (IVH).
METHODS: Preterm infants <32 weeks underwent continuous monitoring of cerebral oxygenation and heart rate over the first 72 h after birth. Serial cranial and cardiac ultrasound assessments were performed to evaluate the ductal status and to diagnose IVH onset. The moving correlation coefficient between cerebral oxygenation and heart rate (TOHRx) was calculated. Linear mixed-effect models were used to analyse the impact of relevant clinical variables on TOHRx. The association between TOHRx and IVH development was also assessed.
RESULTS: Seventy-seven infants were included. A haemodynamically significant patent ductus arteriosus (hsPDA) (β = 0.044, 95% CI: 0.007-0.081) and ongoing dopamine treatment (β = 0.096, 95% CI: 0.032-0.159) were associated with increasing TOHRx, indicating impaired cerebrovascular reactivity. A significant association between TOHRx, mean arterial blood pressure (β = -0.004, 95% CI: -0.007, -0.001) and CRIB-II score (β = 0.007, 95% CI: 0.001-0.015) was also observed. TOHRx was significantly higher in infants developing high-grade IVH compared to those without IVH.
CONCLUSIONS: Dopamine treatment, low blood pressure, hsPDA and high CRIB-II are associated with impaired cerebrovascular reactivity during postnatal transition, with potential implications on IVH development. IMPACT: The correlation coefficient between cerebral oxygenation and heart rate (TOHRx) provides a non-invasive estimation of cerebrovascular reactivity, whose failure has a potential pathogenic role in the development of IVH in preterm infants. This study shows that cerebrovascular reactivity during the transitional period improves over time and is affected by specific clinical and therapeutic factors, whose knowledge could support the development of individualized neuroprotective strategies in at-risk preterm infants. The evidence of increased TOHRx in infants developing high-grade compared to low-grade or no IVH during the transitional period further supports the role of impaired cerebrovascular reactivity in IVH pathophysiology.
© 2022. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35513715     DOI: 10.1038/s41390-022-02090-z

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.953


  37 in total

1.  ICM+: software for on-line analysis of bedside monitoring data after severe head trauma.

Authors:  P Smielewski; M Czosnyka; L Steiner; M Belestri; S Piechnik; J D Pickard
Journal:  Acta Neurochir Suppl       Date:  2005

2.  Elevated cerebral pressure passivity is associated with prematurity-related intracranial hemorrhage.

Authors:  Heather O'Leary; Matthew C Gregas; Catherine Limperopoulos; Irina Zaretskaya; Haim Bassan; Janet S Soul; Donald N Di Salvo; Adré J du Plessis
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

3.  Cerebral autoregulation dynamics in premature newborns.

Authors:  R B Panerai; A W Kelsall; J M Rennie; D H Evans
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

4.  Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants.

Authors:  Janet S Soul; Peter E Hammer; Miles Tsuji; J Philip Saul; Haim Bassan; Catherine Limperopoulos; Donald N Disalvo; Marianne Moore; Patricia Akins; Steven Ringer; Joseph J Volpe; Felicia Trachtenberg; Adré J du Plessis
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

5.  Optimal Mean Arterial Blood Pressure in Extremely Preterm Infants within the First 24 Hours of Life.

Authors:  Cristine Sortica da Costa; Marek Czosnyka; Peter Smielewski; Topun Austin
Journal:  J Pediatr       Date:  2018-09-20       Impact factor: 4.406

6.  Changes in hemodynamics, cerebral oxygenation and cerebrovascular reactivity during the early transitional circulation in preterm infants.

Authors:  Cristine Sortica da Costa; Danilo Cardim; Zoltan Molnar; Wilf Kelsall; Isabel Ng; Marek Czosnyka; Peter Smielewski; Topun Austin
Journal:  Pediatr Res       Date:  2019-04-27       Impact factor: 3.756

7.  Monitoring of Cerebrovascular Reactivity for Determination of Optimal Blood Pressure in Preterm Infants.

Authors:  Cristine Sortica da Costa; Marek Czosnyka; Peter Smielewski; Subhabrata Mitra; Gordon N Stevenson; Topun Austin
Journal:  J Pediatr       Date:  2015-04-17       Impact factor: 4.406

8.  Heart rate passivity of cerebral tissue oxygenation is associated with predictors of poor outcome in preterm infants.

Authors:  S Mitra; M Czosnyka; P Smielewski; H O'Reilly; K Brady; T Austin
Journal:  Acta Paediatr       Date:  2014-08-01       Impact factor: 2.299

Review 9.  Cerebral Autoregulation, Brain Injury, and the Transitioning Premature Infant.

Authors:  Zachary A Vesoulis; Amit M Mathur
Journal:  Front Pediatr       Date:  2017-04-03       Impact factor: 3.418

Review 10.  Measuring Near-Infrared Spectroscopy Derived Cerebral Autoregulation in Neonates: From Research Tool Toward Bedside Multimodal Monitoring.

Authors:  Liesbeth Thewissen; Alexander Caicedo; Petra Lemmers; Frank Van Bel; Sabine Van Huffel; Gunnar Naulaers
Journal:  Front Pediatr       Date:  2018-05-14       Impact factor: 3.418

View more
  1 in total

1.  Transcranial ultrasound diagnostic value of hemodynamic cerebral changes in preterm infants for early-onset sepsis.

Authors:  Chunmei Liu; Chengzhi Fang; Yanyan Shang; Baozhen Yao; Qi He
Journal:  Transl Pediatr       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.